What are the alternatives to Saxenda?

Despite the launch of big sibling “Wegovy”, there is still strong demand for Saxenda. However, the global shortage of weight management medication has taken its toll on the availability of this long-time member of the weight loss establishment. Here are three alternatives and how to get them:

Exploring the alternatives to Saxenda

In the field of weight management medications, Saxenda (based on the active drug, liraglutide) has long been a popular choice for many seeking solutions to combat obesity. Saxenda has been available for many years and can lay claim to be the first “miracle” drug in this area.

However, a global supply shortage of Saxenda has prompted people to explore alternative options. Fortunately, there are great alternatives available, with Wegovy and Rybelsus emerging as standout choices that not only address the shortage issue but also as they tend to be cheaper, easier to administer and result in better weight loss.

All patients will be assessed by a doctor who will help determine the most suitable medicine for you.

Wegovy - up to 15% weight loss

Wegovy, also known as semaglutide, is a game-changing drug which has created a huge amount of interest globally. The Semaglutide Treatment Effect in People with Obesity (STEP) clinical trials showed average weight loss in the region of 15% taking it for 68 weeks with the support of a specialist weight management programme, such as the one offered by CheqUp. Recent trials have also shown it to have a major positive effect on cardiovascular events, such as heart attacks.

Wegovy effectiveness

Wegovy: A weekly injection, not daily.

One of the other major advantages of Wegovy over Saxenda is that it is administered through a weekly injection, rather than daily. Although we contend that the injection is almost painless (and certainly less painful than a host of things which happen to each day) we accept that it is a barrier to some people. Therefore, injecting once a week rather than once a day is a significant advantage to many.

Wegovy: It’s cheaper!

The final reason why most people have now switched to Wegovy is that it is …… cheaper. Wegovy consists of one pen per month (used four times) whereas the top dose of Saxenda consists of five pens per month. This is just one of the reasons why Wegovy is up to £100 cheaper than Saxenda

Rybelsus: An an alternative to Saxenda, in tablet form

For those with type 2 diabetes, Rybelsus forms part of the alternatives to Saxenda, particularly for individuals who prefer oral medications over injectables. Rybelsus contains the same drug as Wegovy: the GLP-1 receptor agonist, Semaglutide.

Convenience of a daily pill

One of Rybelsus's key advantages is its oral form, eliminating the need for injections. This can be particularly appealing to individuals who may have reservations about injectable medications or prefer the convenience of an oral tablet.

Rybelsus's effectiveness is supported by the PIONEER clinical trial program, which indicated significant weight loss in those with type 2 diabetes.

Mounjaro, similar to Wegovy but better

Unlike Wegovy, a similar weight loss drug,  which is classed as GLP-1 medication, Mounjaro adds a second factor, GIP, to give a double benefit.  This combined GLP-1 and GIP receptor agonist works by regulating the body's appetite and metabolism, leading to reduced calorie intake and increased energy expenditure. Its dual action on two key hormones - GLP-1 and GIP - provides a dual-dimension to weight loss, making it a promising option for those struggling with obesity.

Moreover, Mounjaro's potential benefits extend beyond weight loss. Clinical trials have also demonstrated improvements in metabolic parameters such as blood sugar control and lipid profiles.

Mounjaro is available as a pre-filled injection pen with varying doses of tirzepatide (2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg), which is administered under the skin in the stomach area, thigh, or upper arm.

The treatment typically starts with a 2.5mg dose once a week for four weeks and can be increased to 5mg once a week. If deemed necessary by your CheqUp doctor, the dose may be further increased in at least 4-week intervals, up to the maximum dose of 15mg once weekly.

As the most recent SURMOUNT clinical trials indicate average weight loss of over 25% in 18 months of taking the medication. This significantly exceeds the weight loss recorded for Wegovy - 15% in 68 weeks.

Weight loss study Mounjaro

CheqUp’s weight management programme

Beyond offering medications which may be more efficacious, more convenient and cheaper than Saxenda, CheqUp also offers a comprehensive weight management system which is designed to support individuals in their weight loss journey, mirroring the structured approach of clinical trials like STEP and SCALE.

Our weight management system includes personalised guidance from obesity experts who aim to address not only the physical aspects of weight loss but also the behavioural and emotional factors that contribute to successful, sustainable weight management.

You came for one drug, but there alternatives to Saxenda

The Saxenda shortage may have prompted your search for alternatives to Saxenda, and we're here to assure you that effective and accessible options exist. Wegovy and Rybelsus, supported by robust clinical evidence, offer not only relief from the supply chain issues but also superior efficacy and convenience. Coupled with our comprehensive weight management system, we are dedicated to empowering individuals on their journey to successful and sustainable weight loss. Remember, the path to better health is not just about finding an alternative; it's about embracing a holistic approach that prioritises your well-being.

Start your journey today by clicking on the button below.

Published: 01 Dec  2023